Morisawa, Norihiko <br/><br/>
Effectiveness of a fixed combination formula of ombitasvir/paritaprevir/ritonavir for hepatitis C virus infection in patients on maintenance haemodialysis.  [electronic resource] 

 -  Nephrology (Carlton, Vic.)  Jul 2017 
 - 562-565 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1440-1797 
<br/><br/><label>Standard No.: </label>10.1111/nep.13011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Anilides--adverse effects<br/>Antiviral Agents--adverse effects<br/>Carbamates--adverse effects<br/>Cyclopropanes<br/>Disease Progression<br/>Drug Combinations<br/>Drug Compounding<br/>Female<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C--complications<br/>Humans<br/>Japan<br/>Lactams, Macrocyclic<br/>Liver Cirrhosis--diagnosis<br/>Macrocyclic Compounds--adverse effects<br/>Male<br/>Middle Aged<br/>Proline--analogs & derivatives<br/>RNA, Viral--genetics<br/>Renal Dialysis--adverse effects<br/>Renal Insufficiency, Chronic--complications<br/>Ritonavir--adverse effects<br/>Sulfonamides<br/>Sustained Virologic Response<br/>Time Factors<br/>Treatment Outcome<br/>Valine<br/>Viral Load